Nanomaterials and Nanotechnology is a premier journal published by HINDAWI LTD, dedicated to advancing knowledge in the rapidly evolving fields of nanomaterials and nanoscale applications. Established as an Open Access platform since 2011, the journal aims to disseminate high-quality research that provides insights into nanotechnology's manifold aspects, including biotechnology, ceramics and composites, as well as electrical and electronic engineering. With a compelling impact factor reflected in its robust Scopus rankings—placing it in the 80th percentile in Engineering and the 72nd percentile in Biotechnology—it stands as a key resource for researchers, professionals, and students seeking to stay at the forefront of innovation in materials science. The journal occupies a distinguished position in the academic community, featuring studies that explore the synthesis, characterization, and application of nanomaterials, thereby contributing significantly to scientific discourse and technological advancement in this critical area.

Nanofabrication is a leading open-access journal dedicated to advancing the field of nanotechnology through innovative research and comprehensive reviews. Published by the Eurasia Academy Publishing Group (EAPG) since 2014, this journal aims to provide a platform for academic discourse, promoting the latest insights and findings in nanofabrication techniques and applications across diverse domains, including materials science, electronics, and drug delivery systems. With a commitment to accessibility, Nanofabrication ensures that all content is freely available to researchers, professionals, and students worldwide, thereby fostering collaboration and knowledge sharing in the rapidly evolving landscape of nanotechnology. The journal's emphasis on high-quality, peer-reviewed research positions it as an authoritative source for those looking to stay at the forefront of developments in the field.

Colloid and Interface Science Communications is a prestigious peer-reviewed journal published by Elsevier, specializing in the vibrant fields of colloid and surface science, along with biotechnology. With an impressive open access policy initiated in 2022, this journal ensures wide dissemination of groundbreaking research. Its impact is reflected in its high standings within various Scopus category quartiles—ranked Q2 in Biotechnology and Colloid and Surface Chemistry, and Q1 in Materials Chemistry, Physical and Theoretical Chemistry, as well as Surfaces, Coatings and Films for 2023. Furthermore, it boasts exceptional Scopus rankings, including a top percentile position in several materials science categories, indicating its significant contribution to the scientific community. Published in the Netherlands, Colloid and Interface Science Communications aims to foster knowledge sharing and collaboration by providing a platform for innovators and researchers to explore cutting-edge developments in surface phenomena and materials interactions. As a key resource for researchers, professionals, and students alike, it plays a critical role in advancing our understanding and application of colloidal and interface science.

The Journal of Nanoanalysis is a leading publication in the field of nanotechnology, dedicated to advancing the understanding and application of nanoscale analysis methodologies. Published by BORNA SANJESH KIMIA CO-BSK CO, this journal aims to provide a comprehensive platform for researchers, professionals, and students to disseminate cutting-edge findings and innovative approaches in nanomaterials characterization, nanoelectronics, and related areas. With a focus on high-quality peer-reviewed articles, the journal supports the global scientific community in fostering interdisciplinary collaboration and knowledge sharing. Although currently lacking an explicit impact factor, the Journal of Nanoanalysis is poised to make significant contributions to the field, with its commitment to open access and accessibility globally enriching the pool of research available for academic and practical advancements.

ChemNanoMat is a prestigious academic journal published by WILEY-V C H VERLAG GMBH, dedicated to the rapidly evolving fields of nanoscale materials and their applications in diverse areas such as biomaterials, energy engineering, and environmental sustainability. With the journal's ISSN 2199-692X and recognized quality, as evidenced by its Q2 rankings across multiple categories—including Biomaterials and Renewable Energy—ChemNanoMat serves as a crucial platform for researchers, professionals, and students to disseminate their findings and foster collaborations. Operating from Germany, the journal encourages the exploration of innovative materials solutions to meet tomorrow's challenges. While it does not currently offer open access options, it remains highly regarded in the academic community with a competitive impact factor that emphasizes its relevance and influence in guiding future research directions. Covering a broad scope from 2015 through 2024, ChemNanoMat is key for anyone invested in the advancement of materials chemistry and related scientific fields.

Advances in Natural Sciences-Nanoscience and Nanotechnology is a premier academic journal published by IOP Publishing Ltd, dedicated to the dynamic and rapidly evolving field of nanoscience and nanotechnology. With an ISSN of 2043-6254 and E-ISSN 2043-6262, this journal encompasses a diverse spectrum of research encompassing both theoretical frameworks and applied technologies, bridging the gap between engineering, industrial practices, and materials science. Holding a reputable position within the Q3 quartile for Electrical and Electronic Engineering, Q2 in Industrial and Manufacturing Engineering, and Q3 in Materials Science, it ranks significantly due to its robust review process and quality of articles. With a convergence span from 2010 to 2024, the journal aims to foster an open dialogue among researchers and professionals, providing essential insights into cutting-edge advancements and interdisciplinary applications in nanotechnology. The open access policy enhances visibility and accessibility, ensuring that every article extends its reach beyond the confines of traditional scholarly communication. Situated in the United Kingdom, this journal not only bolsters the global discourse on nanoscience but also serves as a critical resource for those at the forefront of research and innovation.

JOURNAL OF NANOPARTICLE RESEARCH, published by SPRINGER, is a pivotal platform in the interdisciplinary field of nanotechnology, encompassing atomic and molecular physics, bioengineering, chemistry, condensed matter physics, and materials science. Operating since 1999 and converging through 2024, this journal presents cutting-edge research and innovations in nanoparticle science, aiming to bridge theoretical studies with practical applications. With a diverse scope that attracts articles ranked in various Q2 and Q3 category quartiles across its fields, including Bioengineering and Nanoscience and Nanotechnology, it ranks favorably within Scopus metrics, ensuring high visibility and impact among researchers. While the journal operates under traditional access models, it remains a critical resource for professionals and students alike, empowering them to advance their knowledge and drive future discoveries in this rapidly evolving area of study.

Nanomedicine Journal, published by Mashhad University of Medical Sciences, serves as a vital platform for research and developments in the dynamic field of nanotechnology applied to medicine. With an ISSN of 2322-3049 and an E-ISSN of 2322-5904, this Open Access journal, operational since 2013, makes cutting-edge research freely accessible to encourage collaborative efforts in this rapidly evolving domain. The journal navigates various areas, including bioengineering, biomedical engineering, materials science, and pharmacology, holding prestigious rankings in categories relevant to these fields. The 2023 Scopus Rankings reveal its significant standing within the scientific community, particularly with a 76th percentile in general medicine. By bridging the gap between laboratory technologies and clinical applications, the Nanomedicine Journal aims to empower researchers, professionals, and students alike to contribute to the innovative landscape of nanomedicine. With a convergence period extending from 2019 to 2024 and an established reputation, this journal is essential for those pursuing advancements in therapeutic solutions and diagnostics through nanotechnology.

The Journal of Nanotechnology, published by Hindawi Ltd., is a premier open-access platform dedicated to delivering high-quality research in the dynamic field of nanotechnology. With the ISSN 1687-9503 and E-ISSN 1687-9511, this journal has been at the forefront of disseminating innovative findings since its transition to open access in 2009, fostering a global dialogue among researchers, professionals, and students. Based in Egypt, the journal maintains its commitment to advancing the material science sector, currently holding a prestigious Q2 ranking in the 2023 Materials Science (miscellaneous) category, reflecting its significant contribution to the field. With a Scopus ranking of #162 out of 463 journals in General Materials Science, placing it in the 65th percentile, the Journal of Nanotechnology serves as a crucial resource for those looking to explore the latest advancements and applications in nanomaterials. The journal invites submissions that align with its scope, which emphasizes interdisciplinary approaches and novel methodologies, promising to enhance both academic and practical aspects of nanotechnology.

EXPERT OPINION ON THERAPEUTIC PATENTS, published by Taylor & Francis Ltd, is a prestigious journal dedicated to the critical analysis and commentary on therapeutic patents, emphasizing their impact on drug discovery and development. With an improving reputation reflected in its 2023 Q1 rankings in Drug Discovery and Pharmacology, this journal stands out as a leading source in the fields of pharmacology and medicine, holding significant relevance with a Scopus ranking in the 90th percentile for its contributions in Drug Discovery and a robust position in Pharmacology. Launched in 1991, the journal consistently engages researchers and professionals seeking to stay at the forefront of innovations in therapeutic patents, thus driving advancements in the pharmaceutical landscape. Although it does not offer Open Access, its comprehensive scope and commitment to quality make it an essential resource for those looking to explore the intersection of intellectual property and pharmacological research.